Lesional overexpression of matrix metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not at earlier stages of atherogenesis

被引:174
作者
de Nooijer, R
Verkleij, CJN
von der Thüsen, JH
Jukema, JW
van der Wall, EE
van Berkel, TJC
Baker, AH
Biessen, EAL
机构
[1] Leiden Univ, Ctr Med, Dept Cardiol, Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands
[3] Univ Glasgow, Glasgow Cardiovasc Res Ctr, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
关键词
adenovirus; atherosclerosis; metalloproteinases; remodeling; vulnerable plaque;
D O I
10.1161/01.ATV.0000197795.56960.64
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Matrix metalloproteinase-9 (MMP-9) is involved in atherosclerosis and elevated MMP-9 activity has been found in unstable plaques, suggesting a crucial role in plaque rupture. This study aims to assess the effect of MMP-9 on plaque stability in apolipoprotein E-deficient mice at different stages of plaque progression. Methods and Results - Atherosclerotic lesions were elicited in carotid arteries by perivascular collar placement. MMP-9 overexpression in intermediate or advanced plaques was effected by intraluminal incubation with an adenovirus (Ad.MMP-9). A subset was coincubated with Ad.TIMP-1. Mock virus served as a control. Plaques were analyzed histologically. In intermediate lesions, MMP-9 overexpression induced outward remodeling, as shown by a 30% increase in media size (p=0.03). In both intermediate and advanced lesions, prevalence of vulnerable plaque morphology tended to be increased. Half of MMP-9 - treated lesions displayed intraplaque hemorrhage, whereas in controls and the Ad. MMP-9/Ad.TIMP-1 group this was 8% and 16%, respectively (p=0.007). Colocalization with neovessels may point to neo-angiogenesis as a source for intraplaque hemorrhage. Conclusion - These data show a differential effect of MMP-9 at various stages of plaque progression and suggest that lesion-targeted MMP-9 inhibition might be a valuable therapeutic modality in stabilizing advanced plaques, but not at earlier stages of lesion progression.
引用
收藏
页码:340 / 346
页数:7
相关论文
共 39 条
  • [1] Development of recombinant adenoviruses that drive high level expression of the human metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 and-2 genes: Characterization of their infection into rabbit smooth muscle cells and human MCF-7 adenocarcinoma cells
    Baker, AH
    Wilkinson, GWG
    Hembry, RM
    Murphy, G
    Newby, AC
    [J]. MATRIX BIOLOGY, 1996, 15 (06) : 383 - 395
  • [2] Belotti D, 2003, CANCER RES, V63, P5224
  • [3] Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury
    Bendeck, MP
    Conte, M
    Zhang, MY
    Nili, N
    Strauss, BH
    Farwell, SM
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (03) : 1089 - 1095
  • [4] Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture
    Bennett, MR
    [J]. CARDIOVASCULAR RESEARCH, 1999, 41 (02) : 361 - 368
  • [5] Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease
    Blankenberg, S
    Rupprecht, HJ
    Poirier, O
    Bickel, C
    Smieja, M
    Hafner, G
    Meyer, J
    Cambien, F
    Tiret, L
    [J]. CIRCULATION, 2003, 107 (12) : 1579 - 1585
  • [6] Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice
    Camp, TM
    Tyagi, SC
    Senior, RM
    Hayden, MR
    Tyagi, SC
    [J]. DIABETOLOGIA, 2003, 46 (10) : 1438 - 1445
  • [7] Vascular endothelial growth factor enhances atherosclerotic plaque progression
    Celletti, FL
    Waugh, JM
    Amabile, PG
    Brendolan, A
    Hilfiker, PR
    Dake, MD
    [J]. NATURE MEDICINE, 2001, 7 (04) : 425 - 429
  • [8] Proteolysis of latent transforming growth factor-β (TGF-β)-binding protein-1 by osteoclasts -: A cellular mechanism for release of TGF-β from bone matrix
    Dallas, SL
    Rosser, JL
    Mundy, GR
    Bonewald, LF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) : 21352 - 21360
  • [9] FUSTER V, 1990, CIRCULATION, V82, P47
  • [10] FUSTER V, 1995, AM J CARDIOL, V76, P24